Prelude Capital Management’s Trueblue TBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
– Sell
-13,500
Closed -$71.7K – 1342
2025
Q1
$71.7K Buy
13,500
+3,000
+29% +$20.5K 0.01% 1070
2024
Q4
$88.2K Buy
+10,500
New +$81.1K 0.01% 1101
2022
Q3
– Sell
-12,887
Closed -$231K – 1902
2022
Q2
$231K Buy
+12,887
New +$302K 0.01% 1216
2020
Q4
– Sell
-294
Closed -$5K – 1966
2020
Q3
$5K Buy
+294
New +$4.53K ﹤0.01% 1570
2019
Q4
– Sell
-1,500
Closed -$32K – 2237
2019
Q3
$32K Buy
+1,500
New +$31K ﹤0.01% 1301
2019
Q2
– Sell
-485
Closed -$11K – 2129
2019
Q1
$11K Sell
485
-2,600
-84% -$60.7K ﹤0.01% 1432
2018
Q4
$69K Buy
+3,085
New +$74K ﹤0.01% 1040
2018
Q3
– Sell
-1,200
Closed -$32K – 2026
2018
Q2
$32K Buy
+1,200
New +$31.8K ﹤0.01% 1247
2017
Q4
– Sell
-700
Closed -$16K – 1700
2017
Q3
$16K Sell
700
-1,200
-63% -$27.1K ﹤0.01% 1359
2017
Q2
$50K Buy
1,900
+297
+19% +$7.93K ﹤0.01% 1005
2017
Q1
$44K Sell
1,603
-9,563
-86% -$244K ﹤0.01% 1049
2016
Q4
$275K Buy
11,166
+2,769
+33% +$58.4K 0.03% 463
2016
Q3
$190K Sell
8,397
-4,066
-33% -$88.8K 0.02% 584
2016
Q2
$236K Sell
12,463
-737
-6% -$15.4K 0.03% 449
2016
Q1
$345K Buy
13,200
+300
+2% +$6.95K 0.05% 371
2015
Q4
$332K Sell
12,900
-900
-7% -$24.3K 0.05% 377
2015
Q3
$310K Buy
13,800
+6,550
+90% +$168K 0.05% 422
2015
Q2
$217K Sell
7,250
-6,997
-49% -$197K 0.03% 557
2015
Q1
$347K Buy
14,247
+7,251
+104% +$163K 0.05% 458
2014
Q4
$156K Sell
6,996
-3,904
-36% -$92.6K 0.02% 798
2014
Q3
$275K Buy
10,900
+6,200
+132% +$172K 0.04% 589
2014
Q2
$130K Sell
4,700
-2,980
-39% -$81.6K 0.02% 984
2014
Q1
$225K Buy
+7,680
New +$206K 0.03% 690
2013
Q4
– Sell
-110
Closed -$3K – 1900
2013
Q3
$3K Buy
+110
New +$2.75K ﹤0.01% 1604

Other funds holding TBI

Prelude Capital Management's TBI Position: Q2 2025 in Review

Prelude Capital Management sold out of Trueblue (TBI) in Q2 2025, closing a stake of 13,500 shares — an estimated $71.7K sold.

Prelude Capital Management first reported a position in TBI in Q3 2013 and held it in 24 quarters. The position peaked at $347K in Q1 2015. 111 funds tracked by Wall St. Rank hold TBI as of Q2 2025.

  • Prelude Capital Management reported no remaining Trueblue position as of Q2 2025 after selling out during the quarter.
  • Prelude Capital Management sold 13,500 Trueblue shares in Q2 2025, an estimated $71.7K.
  • Prelude Capital Management first reported a position in Trueblue in Q3 2013 and held it in 24 quarters.
  • Prelude Capital Management's Trueblue position peaked at $347K in Q1 2015.
  • 111 funds tracked by Wall St. Rank held Trueblue as of Q2 2025.

Based on Prelude Capital Management's 13F filing for Q2 2025, filed 14 Aug 2025.